Spotlight on Prostate Cancer: Why Awareness and Early Detection Matter
St Vincent's Private Hospital Northside
September is Prostate Cancer Awareness Month, providing an opportunity for Australian men to better understand their prostate cancer risk, recognise potential symptoms and have informed conversations with their GP about early detection.
St Vincent's Private Hospital Northside Urologists, Dr William Bowes and Dr Jamie Reynolds.
Prostate cancer is the most commonly diagnosed cancer among Australian men, with almost 29,000 new cases expected to be diagnosed each year. While it predominantly affects older men, advances in screening, diagnosis, and treatment are helping identify more cancers earlier, improving treatment options and long-term outcomes.
At St Vincent's Private Hospital Northside, our urologists are seeing first-hand how greater awareness is encouraging men to be more proactive about their health.
For many men, prostate cancer has historically been an uncomfortable topic of conversation. However, according to St Vincent's Private Hospital Northside urologists Dr William Bowes and Dr Jamie Reynolds, that is beginning to change.
The Importance of Early Detection
One of the challenges with prostate cancer is that it often develops without symptoms in its early stages.
"The most common thing I hear from people when they're diagnosed with prostate cancer is, 'I feel fine'," says Dr Bowes.
"That's the whole point of the PSA test. You're trying to detect cancer when someone is asymptomatic. If you wait until someone develops symptoms, it may be too late."
Urinary symptoms such as changes in frequency or flow can occur with prostate cancer, but they can also be caused by non-cancerous conditions such as an enlarged prostate. Any new or persistent symptoms should be discussed with a GP rather than dismissed or assumed to be cancer.
Symptoms can include:
- Needing to urinate more frequently, particularly at night
- Difficulty starting or stopping urination
- A weak urine stream
- Feeling that the bladder is not fully emptied
- Pain or discomfort when urinating
- Blood in the urine or semen
- Pain in the lower back, hips or pelvis
Early detection can make a significant difference to outcomes, with more than 98 per cent of men diagnosed with early-stage prostate cancer surviving at least five years after diagnosis. (Prostate Cancer Foundation of Australia, 2026)
When to Get Tested
Understanding your personal risk and discussing PSA testing with your GP can be an important part of looking after your prostate health.
"For men with a strong family history, we need to be thinking about testing at a younger age," says Dr Bowes.
Dr Bowes recommends men discuss a baseline PSA test with their GP from age 40.
"I would say that all men over the age of 40 should see their GP and discuss having a baseline PSA test," he says.
For men with a family history of prostate cancer, Dr Reynolds recommends more regular monitoring.
"If they have a family history of prostate cancer, their PSA should then be checked regularly, potentially every year. Other men could have their PSA checked every couple of years," says Dr Reynolds.
SVPHN Urologist, Dr William Bowes
SVPHN Urologist, Dr Jamie Reynolds
Advances in Diagnosis
PSA testing remains an important tool for early detection, but advances in imaging are changing the way prostate cancer is investigated.
The updated guidelines highlight the role of multiparametric MRI (mpMRI) before prostate biopsy for men with an elevated PSA. MRI can help specialists identify clinically significant cancers and may reduce unnecessary biopsies.
Dr Reynolds says advances in imaging are improving diagnosis and treatment planning.
"MRI is better and PET scans are better," he says. "That helps with diagnosis and staging, which means we can make more accurate treatment decisions."
For patients, this means care is increasingly tailored using a combination of PSA results, imaging, specialist assessment and individual risk factors.
A Prostate Cancer Diagnosis Does Not Always Mean Surgery
The use of active surveillance has become increasingly common for appropriately selected men with low-risk prostate cancer.
"Being diagnosed with prostate cancer doesn't automatically mean you need to have your prostate removed or undergo radiotherapy," says Dr Bowes.
Patients with low-volume, low-grade disease may be safely monitored through active surveillance rather than undergoing immediate treatment, helping avoid unnecessary side effects.
St Vincent's Private Hospital Northside
The Benefits of a Multidisciplinary Approach
At St Vincent's Private Hospital Northside, patients can access a multidisciplinary model of care through the Urology Service, bringing together experts to determine the most appropriate treatment pathway for each individual.
"The biggest benefit is that everyone gets together to consider all the options for each individual patient," says Dr Bowes.
Pathology results and imaging can be reviewed collectively, with urologists, radiation oncologists, medical oncologists and radiologists contributing to treatment decisions.
"Not everyone with prostate cancer needs surgery," Dr Bowes explains. "Some patients may be better suited to radiotherapy or active surveillance."
This collaborative approach helps ensure treatment recommendations are tailored to each patient's diagnosis, health status and preferences.
Start the Conversation
Greater awareness is encouraging more men to have conversations about prostate cancer, whether with their GP, family, friends or colleagues.
"Men are having more conversations about prostate cancer, whether that's with friends, colleagues or family members, and I think it has become much easier for men to talk openly about it. That probably wasn't the case 10 or 20 years ago," says Dr Reynolds.
The message from Dr Bowes and Dr Reynolds is simple: don't wait for symptoms before thinking about your prostate health.
Talk to your GP about your risk factors, particularly if you have a family history of prostate cancer.
As Dr Bowes says, feeling well does not necessarily mean everything is well.
"The fact that you're asymptomatic doesn't mean you shouldn't have a conversation with your GP about prostate cancer and PSA testing."